Krebs Biochemicals [KREBSBIO] vs Vaishali Pharma [VAISHALI] Detailed Stock Comparison

Krebs Biochemicals

NSE

Vaishali Pharma

NSE

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Krebs Biochemicals wins in 9 metrics, Vaishali Pharma wins in 9 metrics, with 0 ties. Both stocks appear equally matched on key metrics.

View Metrics Details

Vital Metrics Comparison

Metric	Krebs Biochemicals	Vaishali Pharma	Better
P/E Ratio (TTM)	-5.99	214.50	Krebs Biochemicals
Price-to-Book Ratio	-1.10	2.64	Krebs Biochemicals
Debt-to-Equity Ratio	-1.45	18.98	Krebs Biochemicals
PEG Ratio	-2.05	0.55	Krebs Biochemicals
EV/EBITDA	-26.66	-201.19	Vaishali Pharma
Profit Margin (TTM)	-75.46%	0.38%	Vaishali Pharma
Operating Margin (TTM)	-67.04%	5.16%	Vaishali Pharma
EBITDA Margin (TTM)	N/A	5.16%	N/A
Return on Equity	18.42%	1.68%	Krebs Biochemicals
Return on Assets (TTM)	-15.94%	0.90%	Vaishali Pharma
Free Cash Flow (TTM)	$-114.54M	$6.96M	Vaishali Pharma
1-Year Return	-12.83%	-27.56%	Krebs Biochemicals
Price-to-Sales Ratio (TTM)	4.64	1.58	Vaishali Pharma
Enterprise Value	$3.76B	$1.71B	Krebs Biochemicals
EV/Revenue Ratio	10.48	1.64	Vaishali Pharma
Gross Profit Margin (TTM)	94.72%	14.97%	Krebs Biochemicals
Revenue per Share (TTM)	$17	$8	Krebs Biochemicals
Earnings per Share (Diluted)	$-12.56	$-1.55	Vaishali Pharma
Beta (Stock Volatility)	0.59	0.35	Vaishali Pharma

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Krebs Biochemicals vs Vaishali Pharma Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Krebs Biochemicals	0.44%	-1.02%	-9.61%	0.22%	-12.31%	-23.13%
Vaishali Pharma	-2.55%	3.04%	-4.71%	-2.49%	-18.00%	-29.69%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Krebs Biochemicals	-12.83%	-40.47%	-14.64%	-23.45%	-23.45%	-23.45%
Vaishali Pharma	-27.56%	26.94%	185.55%	189.60%	189.60%	189.60%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Krebs Biochemicals (KREBSBIO): View Full Stock Overview

Vaishali Pharma (VAISHALI): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Krebs Biochemicals vs Vaishali Pharma

Metric	KREBSBIO	VAISHALI
Market Information
Market Cap i	₹1.67B	₹1.65B
Market Cap Category	Small cap	Small cap
10 Day Avg. Volume i	2,038	593,701
90 Day Avg. Volume i	2,939	511,293
Last Close	₹74.89	₹12.21
52 Week Range	₹66.12 - ₹129.07	₹10.30 - ₹24.91
% from 52W High	-41.98%	-50.98%
All-Time High	₹227.90 (Dec 27, 2021)	₹24.91 (Oct 14, 2024)
% from All-Time High	-67.14%	-50.98%
Growth Metrics
Quarterly Revenue Growth	-0.58%	0.31%
Quarterly Earnings Growth	-0.57%	-0.25%
Financial Health
Profit Margin (TTM) i	-0.75%	0.00%
Operating Margin (TTM) i	-0.67%	0.05%
Return on Equity (TTM) i	0.18%	0.02%
Debt to Equity (MRQ) i	-1.45	18.98
Cash & Liquidity
Book Value per Share (MRQ)	₹-67.74	₹4.79
Cash per Share (MRQ)	₹0.07	₹0.14
Operating Cash Flow (TTM) i	₹-132,808,000	₹37.16M
Levered Free Cash Flow (TTM) i	₹-269,393,000	₹7.19M
Dividends
Last 12-Month Dividend Yield i	N/A	N/A
Last 12-Month Dividend i	N/A	N/A

Valuation & Enterprise Metrics Analysis: Krebs Biochemicals vs Vaishali Pharma

Metric	KREBSBIO	VAISHALI
Price Ratios
P/E Ratio (TTM) i	-5.99	214.50
Forward P/E i	N/A	N/A
PEG Ratio i	-2.05	0.55
Price to Sales (TTM) i	4.64	1.58
Price to Book (MRQ) i	-1.10	2.64
Market Capitalization
Market Capitalization i	₹1.67B	₹1.65B
Enterprise Value i	₹3.76B	₹1.71B
Enterprise Value Metrics
Enterprise to Revenue i	10.48	1.64
Enterprise to EBITDA i	-26.66	-201.19
Risk & Other Metrics
Beta i	0.59	0.35
Book Value per Share (MRQ) i	₹-67.74	₹4.79

Financial Statements Comparison: Krebs Biochemicals vs Vaishali Pharma

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	KREBSBIO	VAISHALI
Revenue/Sales i	₹54.81M	₹279.14M
Cost of Goods Sold i	₹2.89M	₹237.35M
Gross Profit i	₹51.92M	₹41.79M
Research & Development i	N/A	N/A
Operating Income (EBIT) i	₹-36.86M	₹12.44M
EBITDA i	₹-20.76M	₹24.35M
Pre-Tax Income i	₹-53.24M	₹19.28M
Income Tax i	₹0	₹4.85M
Net Income (Profit) i	₹-53.24M	₹14.43M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	KREBSBIO	VAISHALI
Cash & Equivalents i	₹1.42M	₹10.21M
Total Current Assets i	₹102.59M	₹983.93M
Total Current Liabilities i	₹1.04B	₹329.65M
Long-Term Debt i	₹1.61B	₹30.20M
Total Shareholders Equity i	₹-1.46B	₹677.63M
Retained Earnings i	N/A	N/A
Property, Plant & Equipment i	₹1.45B	₹13.10M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	KREBSBIO	VAISHALI
Operating Cash Flow i	N/A	N/A
Capital Expenditures i	N/A	N/A
Free Cash Flow i	N/A	N/A
Debt Repayment i	N/A	N/A
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	KREBSBIO	VAISHALI
Shares Short i	N/A	N/A
Short Ratio i	N/A	N/A
Short % of Float i	N/A	N/A
Average Daily Volume (10 Day) i	2,038	593,701
Average Daily Volume (90 Day) i	2,939	511,293
Shares Outstanding i	21.56M	107.19M
Float Shares i	3.93M	70.74M
% Held by Insiders i	0.81%	N/A
% Held by Institutions i	0.00%	N/A

Dividend Analysis & Yield Comparison: Krebs Biochemicals vs Vaishali Pharma

Metric	KREBSBIO	VAISHALI
Last 12-Month Dividend i	N/A	N/A
Last 12-Month Dividend Yield i	N/A	N/A
3-Year Avg Annual Dividend i	N/A	N/A
3-Year Avg Dividend Yield i	N/A	N/A
3-Year Total Dividends i	N/A	N/A
Ex-Dividend Date	N/A	N/A

Krebs Biochemicals [KREBSBIO] vs Vaishali Pharma [VAISHALI] Detailed Stock Comparison